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Abstract
Background: A common genetic variant, rs4939827, located in SMAD7, was identified by two recent genome-wide
association (GWA) studies to be strongly associated with the risk of colorectal cancer (CRC). However, the following
replication studies yielded conflicting results.
Method and Findings: We conducted a case-control study of 641 cases and 1037 controls in a Chinese population and then
performed a meta-analysis, integrating our and published data of 34313 cases and 33251 controls, to clarify the relationship
between rs4939827 and CRC risk. In our case-control study, the dominant model was significant associated with increased
CRC risk [Odds Ratio (OR)=1.46; 95% confidence interval (95% CI), 1.19–1.80]. The following meta-analysis further confirmed
this significant association for all genetic models but with significant between-study heterogeneity (all P for heterogeneity
,0.1). By stratified analysis, we revealed that ethnicity, sample size, and tumor sites might constitute the source of
heterogeneity. The cumulative analysis suggested that evident tendency to significant association was seen with adding
study samples over time; whilst, sensitive analysis showed results before and after removal of each study were similar,
indicating the highly stability of the current results.
Conclusion: Results from our case-control study and the meta-analysis collectively confirmed the significant association of
the variant rs4939827 with increased risk of colorectal cancer. Nevertheless, fine-mapping of the susceptibility loci defined
by rs4939287 should be imposed to reveal causal variant.
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Introduction
Colorectal cancer (CRC) is the third most common cancer and
the fourth leading cause of cancer mortality worldwide [1]. Among
the risk factors and causes for CRC, genetic component has
strongly contributed to CRC development, which accounts for
approximately 35% of total cases as reflected by twin- and family-
based studies [2]. However, so far genetic factors have incom-
pletely been characterized.
Genome-wide association (GWA) study has greatly contributed
to identification of common genetic variants associated to common
disease without prior knowledge of gene function. Several resent
GWA studies have reported multiple novel susceptibility loci to
colorectal cancer [3–11]._ENREF_7 Among these loci, the single
nucleotide polymorphism (SNP, rs4939827), located in 18q21, has
been strongly associated with risk of CRC by multiple GWA
studies [3,10]. Broderick et al. firstly identified rs4939827 in a
GWA set of 620 cases and 960 controls and 3 replication sets of
7377 cases and 5867controls [10], and then Tenesa et al. further
refined this finding in another comprehensive, phased-based GWA
study comprising 16759 cases and 15545 controls [3]. Interestingly,
rs4939827 maps to Mothers against decapentaplegic homolog 7
(SMAD7), a strong candidate gene in the famous transformation
growth factor-b (TGF-b) pathway. SMAD7 acts as an intracellular
antagonist of TGF-b signaling by recruiting SMURF to receptors
for inactivation. Perturbation of SMAD7 and suppression of TGF-b
signaling has been documented to involve in CRC [12]. Much
attention has been drawn to this SNP; however, several follow-up
studies cannot replicate the association [13–16], which may be due
to the sample size. For instance, in Chinese population, Xiong et al.
reported a significant association of this SNP with CRC risk [17],
whereas Li et al. failed to replicate this association [13]. Similar
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1controversial results were also seen in the replication studies in
European [15,16]. These results emphasize a need of additional
replication for large sample size. Herein, we performed a replication
study comprising 641cases and 1037 controls in a Chinese
population. Moreover, meta-analysis is a method combing data
together to make sample size exponential growth to get enough
power to clarify inconsistent results in genetic association studies
[18]. We further conducted a meta-analysis, combining current and
previously published studies about rs4939827, to clarify the real
relationship between this SNP and CRC risk.
Materials and Methods
Study populations
In this study, a total of 641 new CRC cases and 1037 cancer-
free controls were enrolled from between 2009 and 2011 from
Tongji Hospital of Huazhong University of Science and
Technology, Wuhan, China. Cases had been histopathologically
confirmed with primary colorectal cancer and had not received
any treatment prior to blood samples collection. Controls were
randomly selected from a subject pool of individuals who
participate in health check-up programs at the same hospital in
the same time period as the patients were enrolled. Controls were
frequency matched to patients by age (65 years) and gender. All
subjects were unrelated ethnic Han Chinese living in Wuhan
region. At recruitment, a 5-ml peripheral venous blood sample was
collected from each subject after written informed consent was
obtained. This study was approved by ethnics committee of Tongji
Hospital of Huazhong University of Science and Technology.
DNA isolation and genotyping
Genomic DNA was extracted from 5-mL of peripheral blood
sample using the RelaxGene Blood System DP319-02 (Tiangen,
Beijing, China) according to the manufacturer’s instructions. The
genotypes of rs4939827 were determined by using the TaqMan
SNP Genotyping Assay (Applied Biosystems, Foster city, CA) on a
7900HT Fast Real-Time PCR System (Applied Biosystems, Foster
city,CA).Forqualitycontrol,5%duplicatedsampleswererandomly
selected for to assess the reproducibility, with a concordance rate of
100%
Statistical analysis
Pearson x
2 test, fisher exact test, and t test were employed to
evaluate the differences in distribution of demographic character-
istics and genotypes between case and control groups, where
appropriate. Goodness-of-fit x
2 test was adopted to assess Hardy-
Weinberg Equilibrium (HWE) in the controls. Unconditional
multivariate logistic regression analysis was used to estimate odds
ratios (ORs) and their 95% confidence intervals (CIs) for the effect
of rs4939827 genotypes on CRC risk, after adjusting for age and
sex. To avoid the assumptions of genetic models, additive and
dominant models for rs4939827 were also assessed. All statistical
analyses were performed with the SPSS 12.0 software. A value of
P,0.05 was considered representative of statistical significance.
Meta-analysis of rs4939827 in association with CRC risk
To further investigate the association between rs4939827 and
CRC risk, a meta-analysis based on the published studies was
carried out according to the guidelines of Preferred Reporting Items
forSystemicReviewsandMeta-Analysesstatement(PRISMA)[19].
Systematic literature search updated to September, 2011 were
performed in the PubMed and EMBase databases(Figure S1), us-
ing the search strategy based on combinations of the keywords
‘‘rs4939827 or 18q21’’ and ‘‘colorectal cancer, colorectal neoplasia
or colorectal adenoma’’ without language restriction. References
listed in the retrieved articles were also scanned. Reviews,
comments, and letters were also checked for additional studies.
Studies were included if they met the all of the following criteria: (a)
assessment of the association between rs4939827 and CRC risk; (b)
use of a case-control study or nested case-control study design; (c)
information provided on genotype or allele frequency for risk
estimates; (d) the genotype of controls is in Hardy-Weinberg
equilibrium; (e) studies of humans. If the studies had overlapping
subjects, only the study contained the largest population was finally
included. Three reports were excluded due to lack of sufficient data
for calculation of ORs after contacting with individual authors by
E-mail [20–22].
The following data were extracted by two independent authors
(B. Zhu & Q. Song): first author’s last name, country of origin,
publication year, predominant ethnicity of participants, sample size,
study method and design, source of control groups (population- or
hospital-based controls), genotyping method. Counts of alleles and
genotypes in cases and controls were extracted or calculated from
published data. Pooled frequency of the T allele in various ethnic
populations was estimated using the inverse variance method
previously described by Thakkinstian et al [23]. ORs and their 95%
CIs as the metrics of effect size were re-calculated for the genotypes
TT versus CC and CT versus CC. A dominant model was assumed
for rs4939827, and an additive ‘‘per-allele’’ model and a recessive
model were also considered. In this study, we used the Cochran’s Q
statistic to assess heterogeneity (heterogeneity was considered
significant at P,0.1) [24]. The I
2 metric was applied to quantify
heterogeneity irrespective of numbers of studies (I
2=0–25%, no
heterogeneity; I
2=25–50%, moderate heterogeneity; I
2=50–75%,
large heterogeneity; I
2=75–100%, extreme heterogeneity) [25]. A
fixed-effects model, using Mantel-Haenszel method [26], was
appliedtopooldata from studies when heterogeneitywas negligible;
otherwise, a random-effects model, using DerSimonian and Laird
method, was applied [27]. Stratified analyses were performed, if
feasible, according to ethnicity (European, Asian and mixed
population), sample size (#1000 and .1000 subjects), study design
(GWA and replication study) and tumor site (colon, rectum and
colorectal cancers). Sensitivity analysis was also performed to assess
the influence of each individual study on overall estimates by
Table 1. Characteristics of study population.
Variables
Cases (N=641)
No. (%)
Control (N=1037)
No. (%) P
Sex 0.784
a
Male 384 (59.9) 613 (59.1)
Female 257 (40.1) 424 (40.9)
Age (years) 56.31612.59 57.24610.86 0.119
b
Tumor site
Colon 250 (39%)
Rectum 391 (61%)
Duke’s stage
A 83 (12.9%)
B 228 (35.6%)
C 227 (35.4%)
D 103 (16.1%)
aP value was calculated by the x
2 test;
bP value was calculated by the t test.
doi:10.1371/journal.pone.0033318.t001
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was performed to investigate the dynamic trend of the association
between the SNP and CRC with accumulation of studies by
published year [29]. Publication bias was estimated by funnel plot
and Eegger’s test [30,31]. All statistical analyses were carried out by
Stata version 10.0.
Results
Results of case-control study
Population characteristics. A total of 641 incident cases of
colorectal cancer and 1037 frequency-matched controls were
enrolled in this study. As shown in Table 1, males were 59.9%
Table 2. The association between rs4939827 and colorectal cancer risk in a Chinese population.
Controls Cases OR (95% CI)
b
CC/CT/TT CC/CT/TT CT vs. CC TT vs. CC Dominant model Additive model
Total 732/272/33 399/232/10 1.57 (1.27–1.94) – 1.46 (1.19–1.80) 1.27 (1.05–1.52)
Tumor site – –
Colon 732/305
a 149/101
a – – 1.65 (1.24–2.20)
Rectum 732/305
a 250/141
a – – 1.35 (1.06–1.73)
Duke’s stage – –
A+B 732/305
a 184/127
a – – 1.67 (1.28–2.17)
C+D 732/305
a 215/115
a – – 1.28 (0.98–1.67)
aCC/(CT+TT);
bORs and their corresponding 95% CIs were calculated by multivariate logistic regression model after adjusting for age and sex.
doi:10.1371/journal.pone.0033318.t002
Table 3. Characteristics of studies on rs4939827 polymorphisms and risk of colorectal cancer included in the meta-analysis.
First author
Published
year Country Ethnicity
Study
method
Study
design
Genotyping
method
Tumor
site Case/control
Broderick P [10] 2007 UK European Nested CC GWAS Illumina CRC 620/960
UK European CC Replication Allele-PCR CRC 4422/3844
UK European CC Replication Allele-PCR CRC 1992/1680
UK European Nested CC Replication Allele-PCR CRC 963/343
Tenesa A [3] 2008 Scotland European Nested CC GWAS Illumina CRC 2895/3059
Scotland European Nested CC Replication TaqMan-PCR CRC 830/923
Australia European CC Replication TaqMan-PCR CRC 1318/1140
Canada European CC Replication TaqMan-PCR CRC 1173/1182
England European CC Replication TaqMan-PCR CRC 2232/2250
German European CC Replication TaqMan-PCR CRC 2150/2182
Israel European CC Replication TaqMan-PCR CRC 1352/1336
Spain European CC Replication TaqMan-PCR CRC 418/295
Japan Asians CC Replication TaqMan-PCR CRC 4391/3178
Curtin K [14] 2009 Leeds, UK European CC Replication SNPlex CRC 245/216
Sheffield, UK European CC Replication SNPlex CRC 398/400
Utah, USA European CC Replication SNPlex CRC 422/425
Thompson CL [15] 2009 USA Mixed CC Replication TaqMan-PCR Colon 554/709
Mates IN [16] 2010 Romania European CC Replication Centaurus colon, rectum 92/95
Niittymaki I [32] 2010 Finland European CC Replication Sequencing CRC 970/969
Slattery ML [33] 2010 USA Americans CC Replication TaqMan-PCR Colon 1475/2287
Xiong F [17] 2010 China Asians CC Replication T-ARMS-PCR Colon, rectum 2124/2180
von Holst [34] 2010 Sweden European Nested CC Replication deCode test CRC 1782/1679
Li X [13] 2011 China Asians CC Replication Sequenom CRC 138/168
Ho JW [35] 2011 HK, China Asians CC Replicatoin Sequenom CRC 716/714
Zhu B 2011 China Asians CC Replication TaqMan-PCR Colon, rectum 641/1037
Abbreviation: CC, case-control study; CRC, colorectal cancer.
doi:10.1371/journal.pone.0033318.t003
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was56.31 years (612.59) for cases and 57.24 years (610.86) for
controls. There was no significant difference in distribution of sex
(P=0.748) and age (P=0.119) between case and control group. Of
Cases, 39% had colon cancer and 61% had rectum cancer.
Regarding tumor state, 12.9%, 35.6%, 35.4% and 16.1% of cases
were classified as Duke’s A, B, C and D stage at the time of
diagnosis, respectively.
Genotypes in the controls conformed to Hardy-Weinberg
equilibrium (P=0.214). Significant difference in genotype distri-
bution was observed between cases and controls (x
2=21.25,
P,0.001). In the multivariate logistic regression model, individuals
with the CT genotype had a significant, 57% increased risk of
CRC (OR=1.57; 95% CI, 1.27–1.94, P,0.001) compared to
those with the CC homozygote. Due to the low frequency of the
TT genotype (3.2% in controls and 1.6% in cases) in this study
population, a dominant model was perform, by combining the TT
with the CT into an T carrier (TT plus CT) group, and result
showed that the T carrier also present significantly increased risk,
compared with those carrying the CC genotype (OR=1.46;
95%CI, 1.19–1.80, P,0.001). In the allelic model, T allele carriers
also showed significantly increased risk compared to those with the
C allele (OR=1.26; 95% CI, 1.05–1.51, P=0.01). In the additive
model, per-T allele similarly conferred an OR of 1.27 (95% CI,
1.05–1.52, P=0.01) (Table 2).
Wethenstratifieddataaccordingtothepathologicalfactorsunder
the dominant model. The CT plus TT genotypes were both
associated with increased risk of colon and rectal cancers.
Interestingly, the effect of the CT plus TT genotypes was larger in
Figure 1. Forest plot of association of rs4939827 with CRC under allelic model.
doi:10.1371/journal.pone.0033318.g001
Table 4. Pooled OR with 95% CI for the association between
rs4929827 and colorectal cancer risk in the meta-analysis.
Genetic
model OR (95%CI) P
P for
Heterogeneity I
2 (%)
Overall
(n=25) T vs. C 1.18 (1.14–1.22) ,0.001 0.001 55.0
(n=21) TT vs. CC 1.33 (1.21–1.47) ,0.001 ,0.001 60.6
CT vs. CC 1.17 (1.09–1.26) ,0.001 ,0.001 59.1
Dominant 1.22 (1.14–1.31) ,0.001 ,0.001 61.6
Recessive 1.24 (1.17–1.32) ,0.001 0.039 38.4
Additive 1.17 (1.14–1.20) ,0.001 0.001 54.8
doi:10.1371/journal.pone.0033318.t004
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cancer (OR=1.35; 95% CI=1.06–1.73). Regarding the Duke’s
stage, the CT plus TT genotypes were associated with increased risk
in early stage (A+B: OR=1.67; 95% CI, 1.28–2.17) but not in
advanced cancer (C+D: OR=1.28; 95% CI, 0.98–1.67; Table 2).
Results of meta-analysis
Study characteristics. A total of 11 publications plus the
currentstudy,comprising 25 case-controlstudies of 34313cases and
33251 controls, were finally included in this meta-analysis[3,10,
13–17,32–35] , of which, 19 studies were conducted in European
[3,10,16–17,32–34], 5 in Asian [3,13,14,35], and 1 in the mixed
population [15] (Table 3). The report by Broderick et al. only
provided data on allele frequency and thus was only included in the
pooled analysis of allelic OR [10].
Frequency of risk allele in control population. Both signi-
ficant between-study heterogeneity were observed in European and
Asian groups (P for heterogeneity ,0.001). Under random-effects
Table 5. Stratified analysis of the association between rs4939827 genotype and colorectal cancer risk.
Category Genetic model OR (95%CI) PI
2
P for
heterogeneity
Ethnicity
European (n=19) T vs. C 1.18 (1.14–1.24) ,0.001 60.6 ,0.001
European (n=15) TT vs. CC 1.39 (1.26–1.55) ,0.001 61.0 0.001
CT vs.CC 1.17 (1.07–1.27) 0.001 58.6 0.002
Dominant 1.24 (1.13–1.36) ,0.001 64.7 ,0.001
Recessive 1.26 (1.18–1.34) ,0.001 37.4 0.071
Additive 1.18 (1.14–1.21) ,0.001 68.0 ,0.001
Asians (n=5) T vs. C 1.18 (1.12–1.25) ,0.001 0.0 0.584
Asians (n=5) TT vs. CC 1.18 (0.93–1.51) 0.181 47.4 0.107
CT vs.CC 1.23 (1.09–1.39) 0.001 54.4 0.067
Dominant 1.24 (1.13–1.35) ,0.001 28.2 0.234
Recessive 1.11 (0.86–1.43) 0.428 52.6 0.077
Additive 1.18 (1.11–1.25) ,0.001 0.0 0.469
Sample size
Large (n=19) T vs.C 1.19 (1.15–1.24) ,0.001 58.2 ,0.001
Large (n=15) TT vs. CC 1.37 (1.24–1.52) ,0.001 66.0 ,0.001
CT vs.CC 1.22 (1.14–1.30) ,0.001 53.5 0.007
Dominant 1.27 (1.18–1.35) ,0.001 59.3 0.002
Recessive 1.24 (1.15–1.33) ,0.001 53.1 0.008
Additive 1.18 (1.15–1.21) ,0.001 55.9 0.004
Small (n=6) T vs.C 1.07 (0.95–1.21) 0.244 26.8 0.234
Small (n=6) TT vs. CC 1.15 (0.91–1.45) 0.232 18.9 ,0.001
CT vs.CC 0.89 (0.69–1.13) 0.339 45.2 0.104
Dominant 0.96 (0.76–1.22) 0.744 47.5 0.090
Recessive 1.23 (1.05–1.43) 0.011 0.0 0.768
Additive 1.05 (0.95–1.16) ,0.001 29.1 0.217
Tumor site
Colon (n=3) T vs. C 1.07 (0.96–1.20) 0.201 35.7 0.212
Colon (n=5) Dominant 1.03 (0.77–1.38) 0.861 85.6 ,0.001
Rectal (n=3) Dominant 1.24 (1.10–1.41) 0.001 0.0 0.725
Colorectal (n=22) T vs.C 1.19 (1.15–1.23) ,0.001 53.0 0.002
Colorectal (n=16) Dominant 1.20 (1.09–1.33) ,0.001 71.3 ,0.001
Design
GWAS (n=2) T vs.C 1.26 (1.09–1.44) 0.001 66.7 0.083
Replication (n=23) T vs. C 1.17 (1.13–1.22) ,0.001 55.5 0.001
Replication (n=20) TT vs. CC 1.32 (1.19–1.46) ,0.001 62.4 ,0.001
CT vs. CC 1.16 (1.07–1.25) ,0.001 59.2 ,0.001
Dominant 1.21 (1.12–1.30) ,0.001 62.1 ,0.001
Recessive 1.24 (1.16–1.33) ,0.001 39.3 0.037
Additive 1.17 (1.14–1.20) ,0.001 56.9 0.001
doi:10.1371/journal.pone.0033318.t005
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50.1%–52.2%) in European controls, which was markedly higher
than that of 23.4% in Asian controls (95% CI, 18.4%–28.3%)(Figure
S2). These pooled frequencies were similar to those reported in
HapMap database of 0.508 and 0.256 for European and Asian,
respectively.
Overall meta-analysis of rs4939827 in associated with
CRC. As shown in Table 4, significant evidence of heterogeneity
was seen in all genetic models (all P for heterogeneity ,0.05), and
ORs for all genetic models were pooled under random-effects
model. In allelic model, the T allele conferring a pooled OR of 1.18
compared to the C allele (95% CI, 1.14–1.22; Figure 1). Genotypic
ORs of the TT versus CC and CT versus CC were 1.33 (95%CI,
1.21–1.47)and 1.17 (95%CI, 1.09–1.26), respectively. Similarly, the
dominant, recessive and additive models were all associated with
significantly increased risk of CRC.
Stratified analysis. To investigate the potential source of
between-study heterogeneity, stratified analysis was performed
(Table 5). After stratifying by ethnicity, significant heterogeneity still
existed in European, whereas in Asian heterogeneity was effectively
reduced. In European population, the variant in all genetic models
presented significantly increased risk of CRC. In Asian population, all
the genetic models except for the TT genotypic and recessive models
were associated with increased risk of CRC, potentially suggesting that
the T variant act in various manners between different ethnical
populations. When stratified by sample size, we defined the large group
when the sample size was more than 1000, otherwise was small group,
heterogeneity was almost removed in small sample subgroup but not
large sample subgroup. Significant association of CRC risk with the
variant remained in large sample studies for all geneticmodels, whereas
only the recessive model showed significant result in small sample
subgroup. According to tumor site, only the data on dominant model
was available. For colon cancer, heterogeneity was still observed and
no significant association was found, whereas the dominant model was
significantly associated with increased risk of rectum cancer without
evidence of heterogeneity. Regarding study design, GWA studies were
merely pooled in allelic model due to limited studies for assessing
genotypic model. Heterogeneity did not change after stratifying by
GWAS and replication and significant association still existed.
Sensitivity analyses and cumulative meta-analysis. Due
to the significant between-study heterogeneity for all genetic
models, sensitivity analysis was performed, by removing the
individual studies sequentially under random-effects model, to
assess the effect of each study on the pooled estimate. As shown in
Table 6, the pooled OR for the allelic model was similar before
and after elimination of each study. Similar results were seen for
other genetic models that no single study dramatically change the
pooled ORs, indicating the robust stability of the current results.
Accumulative meta-analysis was carried out via the assortment
of studies by publication time. As shown by Figure 2, in the allelic
model, the 95% CIs for the pooled OR became increasingly
narrower with each accumulation of more studies, indicating the
progressively boosted precision of the estimation by continual
adding more samples. Simultaneously, inclinations toward signif-
icant association were evident over time. Similar results were seen
in other genetic models.
Publication Bias. As reflected by the funnel plot (Figure S3.)
and Egger’s test, no evidence of publication bias was observed in
all genetic models (all P for egger’s test.0.05).
Discussion
rs4939827 located at 18q21 was revealed to be associated with CRC
risk by two GWA studies, but inconsistent results have been reported
bymultiple following replicationstudies.In this study,we initiallyfound
a significant association between the variant 4939827 and increased
risk of CRC in a case-control set of a Chinese population. Then the
following meta-analysis, first to integrate GWA and replication data
from 25 case-control studies of 34313 cases and 33251 controls,
consistently indicated the significant association of rs4939827 with the
risk of CRC. This significant association was further confirmed by
cumulative meta-analysis, presenting the effect of the variant got
increasingly significant with each accumulating of more data over time.
rs4939827 is located in intron 3 of SMAD7,which encodes a inhibitory
SMAD protein that function as a negatively feedback regulator of
TGF-b signals [36]. There was evidence that the over-expression of
SMAD7 could promote tumorigenesis via disturbing TGF-b-induced
growth inhibition and apoptosis. Although we herein confirmed the
association between the rs4939827 and CRC risk, whether this SNP is
causative was still uncertain. Intriguingly, Houlston et al. have
identified a novel C to G SNP unlisted in dbSNP (MAF=0.47),
through re-sequencing the linkage disequilibrium (LD) region tagged
by rs4939827 in 2532 CRC cases and 2607 controls, was maximally
associated with CRC risk [37]. The following functional models
further provided evidence for the role of this SNP in transcription
factor binding, proposing that this functional SNP was likely to be one
of the causal variants in susceptibility loci tagged by rs4939827.
Table 6. Sensitivity analysis of allelic model.
Study omitted OR (95%CI)
P for
heterogeneity I
2
Broderick 2007 (GWAS) [10] 1.17 (1.13–1.22) 0.001 53.5%
Broderick 2007 (B) 1.18 (1.14–1.23) 0.001 54.6%
Broderick 2007 (C) 1.17 (1.13–1.22) ,0.001 56.1%
Broderick 2007 (D) 1.18 (1.14–1.23) ,0.001 56.2%
Tenesa 2008 (Scotland GWAS) [3]1.17 (1.13–1.22) ,0.001 56.9%
Tenesa 2008 (Scotland
Replication)
1.19 (1.14–1.23) 0.001 53.7%
Tenesa 2008 (Australia) 1.18 (1.13–1.22) ,0.001 56.3%
Tenesa 2008 (Canada) 1.18 (1.13–1.22) ,0.001 56.9%
Tenesa 2008 (England) 1.17 (1.13–1.22) 0.001 55.6%
Tenesa 2008 (German) 1.17 (1.13–1.22) 0.001 54.9%
Tenesa 2008 (Israel) 1.17 (1.13–1.20) 0.046 35.3%
Tenesa 2008 (Spain) 1.18 (1.14–1.22) ,0.001 56.9%
Tenesa 2008 (Japan) 1.18 (1.13–1.22) ,0.001 56.9%
Curtin 2009 (UK-Leeds) [17] 1.18 (1.13–1.22) ,0.001 56.7%
Curtin 2009 (UK-Sheffield) 1.18 (1.14–1.23) 0.001 53.9%
Curtin 2009 (USA-Utah) 1.18 (1.13–1.22) ,0.001 56.9%
Thompson 2009 [15] 1.19 (1.14–1.23) 0.001 52.6%
Xiong 2010 [13] 1.18 (1.13–1.22) ,0.001 56.9%
Mates 2010 [16] 1.18 (1.14–1.22) 0.001 54.3%
Niittymaki 2010 [32] 1.18 (1.13–1.22) ,0.001 56.9%
Slattery 2010 [33] 1.18 (1.14–1.22) 0.001 55.6%
von Holst 2010 [34] 1.18 (1.14–1.23) 0.001 54.7%
Li 2011 [14] 1.18 (1.14–1.23) 0.001 54.9%
Ho 2011 [35] 1.18 (1.13–1.22) ,0.001 56.9%
Zhu 2011 1.18 (1.13–1.22) ,0.001 56.6%
Combined 1.18 (1.14–1.22) 0.001 55.0%
doi:10.1371/journal.pone.0033318.t006
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PLoS ONE | www.plosone.org 6 March 2012 | Volume 7 | Issue 3 | e33318Nevertheless, the obvious evidence of between-study heterogeneity
in this meta-analysis should be issued. We have applied a
comprehensive stratified analysis to interrogate the potential source
of heterogeneity. After stratifying by ethnicity, heterogeneity was
largely reduced in Asian, reflecting ethnicity could partly explain the
heterogeneity. The further supports of that came from the evidence
that various manners the T variant likely act in and different allele
frequenciesbetween EuropeanandAsianpopulations.Whenstratified
by tumor sites, rectum cancer subgroup did not show heterogeneity
anymore, suggesting tumor sites might also be a potential source of
heterogeneity. Additionally, significant association only presented for
rectum cancer, which was inconsistent with our case-control study,
possibly due to our small sample size for stratification by tumor sites.
Regarding sample size, heterogeneity was almost removed in small
sample studies but not large sample subgroup, possibly due to more
complex confounding factors introduced into large sample. Significant
association remained in large sample studies for all genetic models,
whereas only the recessive model showed significant result in small
sample subgroup, reflecting the limited power of small sample size to
detect the modest effect of the variant. Taken together, we revealed
that the ethnicity, tumor sites, and sample size might constitute source
of heterogeneity in this meta-analysis. Whilst, the significant
association of rs4939827 presented in the subgroup of replication
studies, consistent with the result from GWA study subgroup,
suggested this meta-analysis succeed in amplifying power to detect
the modest effect of this variant by pooling data across studies.
Furthermore, the sensitivity analysis and publication bias assessment
indicated the current results from this meta-analysis were stable.
Despite the clear strengthen of this study that applied a
comprehensive analysis strategy, several limitations should be
Figured out. First, the sample size of our case-control study was
relatively small. Nevertheless, the following meta-analysis with
enough power has drawn the consistent result with our case-
control study. Second, the analysis of separate effect for colon or
rectum cancer conferred limited power, and more studies are
needed. Additionally, CRC is a complex trait corporately
influenced by genetic and environmental factors; however, lacking
the environment data limited us to further assess gene-environ-
ment interaction.
In conclusion, our study in a Chinese population and this meta-
analysis collectively confirm the significant association between
SNP rs4939827 and the colorectal cancer risk in European and
Asian populations. However, although a novel SNP in highly LD
with rs4939827 has been proposed to be causal, further fine-
mapping of the CRC susceptibility loci tagged by rs4939827 is
warranted to uncover more causal variants, especially for the low-
frequency or rare functional variants.
Supporting Information
Figure S1 Flow chart of study selection.
(TIF)
Figure 2. Cumulative meta-analysis of association rs4939827 with CRC under allelic model.
doi:10.1371/journal.pone.0033318.g002
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Asian population.
(TIF)
Figure S3 Funnel plot of publication bias under allelic
model.
(TIF)
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